NICHOLE MILLER: Open Payments
NPI 1356806830 · OPELOUSAS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,127 in 141 payments from 16 companies in 2025. Trend: 2023 $2,606 · 2024 $2,347 · 2025 $3,127
Food & beverage: $3,127
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 18 | $619 |
| GlaxoSmithKline, LLC. | 26 | $524 |
| AstraZeneca Pharmaceuticals LP | 20 | $513 |
| Regeneron Healthcare Solutions, Inc. | 16 | $405 |
| Viatris Specialty LLC | 20 | $241 |
| Verona Pharma, Inc. | 8 | $237 |
| Baxter Healthcare | 9 | $157 |
| Insmed, Inc. | 6 | $102 |
| Grifols USA, LLC | 3 | $64 |
| Actelion Pharmaceuticals US, Inc. | 2 | $59 |
Products named: DUPIXENT, NUCALA, FASENRA, YUPELRI, Ohtuvayre, TRELEGY ELLIPTA, Hillrom - Vest System Model 105 Home Care, BREZTRI.
Industry payments across LA — which companies pay providers there.
